HPV Vaccine Shows Direct Impact on Preventing Cervical Cancer Deaths in Young Women
A landmark analysis has found that no young women in England who were eligible for the human papillomavirus (HPV) vaccine have died from cervical cancer in recent years. This marks the first direct evidence that widespread HPV vaccination not only reduces infections and cases of cervical cancer but also saves lives.
The HPV vaccine was introduced in the UK in 2008 and is offered to girls typically aged 12–13. Health authorities have long known the vaccine dramatically reduces HPV infections, which are responsible for nearly all cases of cervical cancer. However, this new data provides the clearest demonstration yet of the vaccine's life-saving impact at the population level.
Cervical cancer is largely preventable through both vaccination and regular screening. The success in England highlights the importance of maintaining high vaccination coverage and encouraging young people to complete the full vaccine course. Public health experts say the findings underscore vaccination as one of the most effective tools in cancer prevention.